Albarico, Antonio S.

HRN: 08-43-10  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/17/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/17/2023
02/24/2023
IV
600mg
Q8
Open Wounds
Waiting Final Action 
02/17/2023
CEFUROXIME 750MG (VIAL)
02/17/2023
02/24/2023
IV
750mg
Q8
Open Wounds
02/18/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/18/2023
02/25/2023
IV
1.5gram
Q6hrs
CAP-MR
Waiting Final Action 
03/01/2023
CEFIXIME 200MG (CAP)
03/01/2023
03/07/2023
ORAL
200mg
BID
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: